We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Automated Gram Smears Equated to Manual Preparations

By LabMedica International staff writers
Posted on 23 Jul 2013
A comparison has been made of Gram smear preparations for identifying bacteria by both a manual method and a Walk Away Specimen Processor (WASP). More...


It is recommended that 30 µL of ESwab sample is the optimal volume for the preparation of manual or automated Gram smears with representation of all elements important for a clinical outcome.

Microbiologists at the Algemeen Medisch Laboratorium (AML; Antwerp, Belgium) analyzed 300 genital samples submitted to the laboratory for routine investigation. All samples were collected with eSwab (Copan Italia; Brescia, Italy) and two smears were prepared from all collected samples.

One smear was prepared manually, by directly streaking the flocked swab from the eSwab sample collection onto a glass slide and dried at room temperature. The second smear was prepared automatically on the Copan WASP with the extended Gram SlidePrep Module. A protocol for smear preparation had been created on the WASP using the 10-µL loop. Both manual and automated prepared smears were fixed with 95% methanol for one minute, stained using the Elitech Gram reagents and methodology (Wescor Inc.; South Logan, UT, USA) and examined under a light microscope with 10 × 100 magnification.

Smears were semiquantitatively evaluated for the presence of the following elements: Lactobacillus, Gardnerella vaginalis, clue-cells, Mobiluncus species, leucocytes, and epithelial cells. The number of Lactobacillus, G. vaginalis, clue-cells, and Mobiluncus present on each smear was also evaluated using the Nugent score system to diagnose bacterial vaginosis. Manual prepared smears had 78% Lactobacillus, 16.6% G. vaginalis, 4.6% Mobiluncus species, and 13.6% clue-cells, while the WASP prepared smear detected 72%, 16%, 5%, and 15% respectively with 10 µL of eSwab sample.

The authors concluded that Gram smears, prepared with 10 µL of eSwab sample on the WASP, had similar number of microorganisms compared to the manual Gram smear in the presence of leucocytes and epithelial cells. The use of the 10-µL loop instead of the 30 µL on the WASP improved the workflow by avoiding changing the loop while processing the same sample. The study was presented at the American Society of Microbiology annual meeting held May18-21, 2013, in Denver (CO, USA).

Related Links:
Algemeen Medisch Laboratorium
Copan Italia
Wescor Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.